News
The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...
CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.
KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...
Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...
A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has continued to show impressive results in clinical trial, with an update at the EHA congress showing long-term effects on ...
Bayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed by US biotech Mammoth Biosciences. The German group is paying $40 ...
The BAC DNA MiniPrep Kit is designed for the rapid preparation of BACs (bacterial artificial chromosomes) and other large DNA constructs from small batch cultures of Escherichia coli. Purification ...
Ampli1 LowPass Kit applications include the characterization and investigation of genomic heterogeneity and evolution in tumor cell populations such as individual circulating tumor cells (CTCs).
Bull or Bear, Seeking Alpha is there Markets change, but our community always has the latest in-depth analysis and powerful stock ratings. New! Get unlimited access to breaking stock news—for free.
Contribute to matthewbhlau/crispr-kit development by creating an account on GitHub.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results